Health Policy and Management, Oncology, and Medicine, Johns Hopkins University, Baltimore, MD, USA.
Cancer J. 2010 Sep-Oct;16(5):507-13. doi: 10.1097/PPO.0b013e3181f45877.
Dyspnea, nausea and vomiting, anorexia, fatigue, and sleep disturbances are common and distressing in advanced cancer. We updated previous systematic reviews of how these symptoms can be alleviated with targeted literature searches. The approach to these symptoms requires comprehensive symptom assessment; treating underlying causes when benefits exceed risks; prioritizing treatment, as patients usually have many symptoms; and addressing psychosocial and spiritual distress. For dyspnea, evidence supports systemic opioids and nonpharmacological treatments such as a fan. The strongest evidence supports metoclopramide for cancer-related nausea and octreotide for bowel obstruction. For anorexia, enteral or parenteral nutrition is indicated with obstruction and expected prognosis of at least 6 weeks. Evidence supports several drugs for appetite affecting quality of life. For fatigue, evidence supports psychosocial interventions and methylphenidate. For insomnia, evidence supports cognitive-behavioral therapy in cancer; no sleep agents have superior effectiveness.
呼吸困难、恶心和呕吐、食欲不振、乏力和睡眠障碍在晚期癌症中很常见且令人痛苦。我们对这些症状的治疗方法进行了更新,对目标文献进行了系统检索。这些症状的治疗方法需要全面的症状评估;在获益超过风险的情况下治疗潜在病因;根据患者通常存在多种症状进行治疗优先级排序;以及解决心理社会和精神困扰。对于呼吸困难,有证据支持使用全身性阿片类药物和非药物治疗方法,如风扇。最有力的证据支持甲氧氯普胺治疗癌症相关性恶心和奥曲肽治疗肠梗阻。对于食欲不振,有阻塞且预计预后至少为 6 周的情况下,建议进行肠内或肠外营养。有证据支持几种影响生活质量的食欲药物。对于乏力,有证据支持心理社会干预和哌甲酯。对于失眠,有证据支持癌症患者的认知行为疗法;没有哪种睡眠药物具有卓越的疗效。